Ubs Group Ag Ocugen, Inc. Put Options Transaction History
Ubs Group Ag
- $528 Billion
- Q1 2025
Put Options
1 transactions
Others Institutions Holding OCGN
# of Institutions
119Shares Held
73MCall Options Held
593KPut Options Held
229K-
Black Rock Inc. New York, NY17.9MShares$13.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.7MShares$12.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.89MShares$5.24 Million0.0% of portfolio
-
State Street Corp Boston, MA5.93MShares$4.51 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA4.15MShares$3.16 Million0.16% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $165M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...